Literature DB >> 17892958

Myotonic dystrophy type I in childhood Long-term evolution in patients surviving the neonatal period.

Bernard Echenne1, Aline Rideau, Agathe Roubertie, Guillaume Sébire, François Rivier, Bernard Lemieux.   

Abstract

In a retrospective study, 32 patients with myotonic dystrophy, including congenital (n=17) and infantile/juvenile forms (n=15) were studied during a long follow-up lasting 7-28 years (median: 17 years). The clinical presentation was extremely variable; however, a continuum did exist between severe and less severe congenital forms, and later-onset forms, without genotype-phenotype correlation. We observed some unusual presentations, such as 3 cases of isolated club-feet during the neonatal period, and 7 patients (23%) with a completely isolated mental deficiency, language delay and school failure, who only completed the clinical picture several years later. Wechsler scale testing was performed in all cases, and repeated with 8 patients. It demonstrated a decrease in intellectual abilities in 5 patients, suggesting the possibility of a degenerative cerebral process occurring in these children. This decrease has also been reported in some adult cases. This study illustrates the extremely heterogeneous clinical presentation of myotonic dystrophy in childhood.

Entities:  

Mesh:

Year:  2007        PMID: 17892958     DOI: 10.1016/j.ejpn.2007.07.014

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  19 in total

1.  12-Month progression of motor and functional outcomes in congenital myotonic dystrophy.

Authors:  Kellen H Quigg; Kiera N Berggren; Melissa McIntyre; Kameron Bates; Francesca Salmin; Jacopo L Casiraghi; Adele DʼAmico; Guja Astrea; Federica Ricci; Marnee J McKay; Jennifer N Baldwin; Joshua Burns; Craig Campbell; Valeria A Sansone; Nicholas E Johnson
Journal:  Muscle Nerve       Date:  2021-01-10       Impact factor: 3.217

2.  Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.

Authors:  Jean-Pierre Bouchard; Louise Cossette; Guillaume Bassez; Jack Puymirat
Journal:  J Neurol       Date:  2014-11-08       Impact factor: 4.849

3.  If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).

Authors:  James E Hilbert; John T Kissel; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Donald B Sanders; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  Contemp Clin Trials       Date:  2011-11-26       Impact factor: 2.226

Review 4.  Congenital myotonic dystrophy: ventriculomegaly and shunt considerations for the pediatric neurosurgeon.

Authors:  Ian S Mutchnick; Meena A Thatikunta; William C Gump; Dan L Stewart; Thomas M Moriarty
Journal:  Childs Nerv Syst       Date:  2016-01-08       Impact factor: 1.475

Review 5.  Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.

Authors:  Genevieve Ho; Michael Cardamone; Michelle Farrar
Journal:  World J Clin Pediatr       Date:  2015-11-08

Review 6.  Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy.

Authors:  Marie Douniol; Aurélia Jacquette; Jean-Marc Guilé; Marie-Laure Tanguy; Nathalie Angeard; Delphine Héron; Monique Plaza; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-06-19       Impact factor: 4.785

7.  Simple Repeat-Primed PCR Analysis of the Myotonic Dystrophy Type 1 Gene in a Clinical Diagnostics Environment.

Authors:  Philippa A Dryland; Elaine Doherty; Jennifer M Love; Donald R Love
Journal:  J Neurodegener Dis       Date:  2013-11-11

Review 8.  Molecular genetics and genetic testing in myotonic dystrophy type 1.

Authors:  Dušanka Savić Pavićević; Jelena Miladinović; Miloš Brkušanin; Saša Šviković; Svetlana Djurica; Goran Brajušković; Stanka Romac
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

9.  Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.

Authors:  Aline Huguet; Fadia Medja; Annie Nicole; Alban Vignaud; Céline Guiraud-Dogan; Arnaud Ferry; Valérie Decostre; Jean-Yves Hogrel; Friedrich Metzger; Andreas Hoeflich; Martin Baraibar; Mário Gomes-Pereira; Jack Puymirat; Guillaume Bassez; Denis Furling; Arnold Munnich; Geneviève Gourdon
Journal:  PLoS Genet       Date:  2012-11-29       Impact factor: 5.917

10.  Expanded DMPK repeats in dizygotic twins referred for diagnosis of autism versus absence of expanded DMPK repeats at screening of 330 children with autism.

Authors:  Zuzana Musova; Miroslava Hancarova; Marketa Havlovicova; Radka Pourova; Michal Hrdlicka; Josef Kraus; Marie Trkova; David Stejskal; Zdenek Sedlacek
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-19       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.